Samuel Dominguez
Concepts (556)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Enterovirus Infections | 26 | 2023 | 165 | 8.790 |
Why?
| Respiratory Tract Infections | 21 | 2023 | 335 | 5.590 |
Why?
| Mucocutaneous Lymph Node Syndrome | 18 | 2022 | 77 | 5.250 |
Why?
| Enterovirus D, Human | 14 | 2023 | 76 | 4.050 |
Why?
| Disease Outbreaks | 20 | 2023 | 333 | 4.040 |
Why?
| Myelitis | 11 | 2019 | 87 | 3.570 |
Why?
| Enterovirus | 11 | 2019 | 72 | 3.240 |
Why?
| Molecular Diagnostic Techniques | 9 | 2021 | 94 | 3.120 |
Why?
| Coronavirus | 10 | 2015 | 42 | 3.110 |
Why?
| Meningitis | 8 | 2022 | 74 | 3.100 |
Why?
| Multiplex Polymerase Chain Reaction | 10 | 2023 | 47 | 3.080 |
Why?
| Influenza, Human | 13 | 2023 | 566 | 2.910 |
Why?
| Encephalitis | 11 | 2022 | 128 | 2.600 |
Why?
| Child, Preschool | 69 | 2023 | 9755 | 2.590 |
Why?
| Gastroenteritis | 5 | 2023 | 65 | 2.400 |
Why?
| Child | 93 | 2023 | 19561 | 2.390 |
Why?
| Anti-Infective Agents | 5 | 2022 | 248 | 2.320 |
Why?
| Infant | 53 | 2023 | 8523 | 2.180 |
Why?
| Influenza A Virus, H1N1 Subtype | 7 | 2020 | 147 | 2.080 |
Why?
| Immunoglobulins, Intravenous | 6 | 2020 | 130 | 2.070 |
Why?
| Central Nervous System Viral Diseases | 4 | 2019 | 62 | 2.060 |
Why?
| Feces | 9 | 2023 | 410 | 2.040 |
Why?
| Neuromuscular Diseases | 4 | 2019 | 89 | 2.000 |
Why?
| Diarrhea | 6 | 2023 | 181 | 1.930 |
Why?
| Colorado | 37 | 2023 | 4325 | 1.870 |
Why?
| Paralysis | 4 | 2018 | 68 | 1.790 |
Why?
| Coronavirus Infections | 9 | 2020 | 349 | 1.680 |
Why?
| Nervous System Diseases | 5 | 2020 | 265 | 1.670 |
Why?
| Infliximab | 4 | 2019 | 95 | 1.620 |
Why?
| Hospitals, Pediatric | 11 | 2021 | 507 | 1.550 |
Why?
| Central Nervous System Infections | 2 | 2022 | 38 | 1.530 |
Why?
| Clostridium Infections | 5 | 2020 | 61 | 1.520 |
Why?
| Simplexvirus | 3 | 2020 | 85 | 1.500 |
Why?
| Cerebrospinal Fluid | 6 | 2019 | 92 | 1.440 |
Why?
| Humans | 140 | 2023 | 122796 | 1.420 |
Why?
| Epidemiological Monitoring | 3 | 2020 | 50 | 1.310 |
Why?
| Retrospective Studies | 38 | 2023 | 13433 | 1.300 |
Why?
| Respiratory Syncytial Virus, Human | 3 | 2023 | 61 | 1.300 |
Why?
| Stevens-Johnson Syndrome | 3 | 2017 | 34 | 1.280 |
Why?
| Pandemics | 11 | 2023 | 1401 | 1.270 |
Why?
| Bacteremia | 3 | 2019 | 169 | 1.250 |
Why?
| Respiratory Syncytial Virus Infections | 3 | 2023 | 103 | 1.240 |
Why?
| Chiroptera | 4 | 2014 | 50 | 1.240 |
Why?
| Intensive Care Units, Pediatric | 4 | 2021 | 213 | 1.230 |
Why?
| Polymerase Chain Reaction | 12 | 2023 | 1021 | 1.220 |
Why?
| Anti-Bacterial Agents | 14 | 2023 | 1562 | 1.220 |
Why?
| Male | 80 | 2023 | 59639 | 1.220 |
Why?
| Bacterial Infections | 2 | 2020 | 234 | 1.210 |
Why?
| Nasopharynx | 5 | 2023 | 66 | 1.200 |
Why?
| Picornaviridae Infections | 5 | 2019 | 29 | 1.200 |
Why?
| Spike Glycoprotein, Coronavirus | 8 | 2022 | 98 | 1.180 |
Why?
| Communicable Diseases | 2 | 2017 | 135 | 1.050 |
Why?
| Female | 72 | 2023 | 63629 | 1.040 |
Why?
| Hospitalization | 14 | 2023 | 1914 | 0.970 |
Why?
| Otitis Media | 2 | 2023 | 149 | 0.960 |
Why?
| Child, Hospitalized | 2 | 2023 | 47 | 0.960 |
Why?
| RNA, Viral | 10 | 2020 | 597 | 0.930 |
Why?
| Antiviral Agents | 6 | 2020 | 670 | 0.920 |
Why?
| Adolescent | 39 | 2021 | 18948 | 0.910 |
Why?
| Coronaviridae | 2 | 2014 | 3 | 0.900 |
Why?
| Bacteria | 6 | 2023 | 772 | 0.900 |
Why?
| Parechovirus | 3 | 2019 | 7 | 0.880 |
Why?
| Drug Resistance, Bacterial | 3 | 2022 | 163 | 0.860 |
Why?
| Blood Culture | 1 | 2021 | 10 | 0.820 |
Why?
| Diagnostic Tests, Routine | 2 | 2019 | 91 | 0.820 |
Why?
| Nervous System Malformations | 1 | 2022 | 33 | 0.820 |
Why?
| Rhinovirus | 5 | 2017 | 40 | 0.810 |
Why?
| Virus Cultivation | 2 | 2018 | 25 | 0.800 |
Why?
| Infant, Newborn | 17 | 2021 | 5430 | 0.790 |
Why?
| Enteropathogenic Escherichia coli | 1 | 2020 | 1 | 0.790 |
Why?
| Enterotoxigenic Escherichia coli | 1 | 2020 | 3 | 0.790 |
Why?
| Cranial Nerve Diseases | 3 | 2017 | 42 | 0.790 |
Why?
| Osteomyelitis | 2 | 2020 | 110 | 0.770 |
Why?
| Bone Diseases, Infectious | 1 | 2020 | 8 | 0.760 |
Why?
| Cross Infection | 3 | 2019 | 218 | 0.750 |
Why?
| Hospitals | 4 | 2021 | 633 | 0.750 |
Why?
| Adenoviridae Infections | 2 | 2023 | 15 | 0.750 |
Why?
| Escherichia coli Infections | 1 | 2020 | 110 | 0.730 |
Why?
| Acyclovir | 1 | 2020 | 104 | 0.720 |
Why?
| Serratia Infections | 1 | 2019 | 6 | 0.720 |
Why?
| Serratia marcescens | 1 | 2019 | 12 | 0.720 |
Why?
| Receptors, Virus | 3 | 2017 | 78 | 0.700 |
Why?
| Genetic Diseases, X-Linked | 1 | 2019 | 24 | 0.700 |
Why?
| Herpesvirus 6, Human | 2 | 2019 | 13 | 0.700 |
Why?
| Agammaglobulinemia | 1 | 2019 | 33 | 0.690 |
Why?
| Equipment Contamination | 1 | 2019 | 56 | 0.690 |
Why?
| Syringes | 1 | 2019 | 40 | 0.690 |
Why?
| Drug Utilization | 2 | 2017 | 183 | 0.690 |
Why?
| Antimicrobial Stewardship | 2 | 2020 | 95 | 0.690 |
Why?
| Neisseriaceae Infections | 1 | 2018 | 5 | 0.680 |
Why?
| Pneumonia, Mycoplasma | 2 | 2017 | 33 | 0.680 |
Why?
| Kingella kingae | 1 | 2018 | 8 | 0.680 |
Why?
| Meningitis, Bacterial | 1 | 2019 | 50 | 0.680 |
Why?
| Coronary Vessels | 2 | 2018 | 237 | 0.670 |
Why?
| Adenoviridae | 3 | 2023 | 195 | 0.670 |
Why?
| Steroids | 1 | 2019 | 156 | 0.670 |
Why?
| Herpes Simplex | 2 | 2018 | 94 | 0.670 |
Why?
| Enterovirus A, Human | 1 | 2018 | 12 | 0.660 |
Why?
| Fluoxetine | 1 | 2018 | 47 | 0.660 |
Why?
| Pneumonia, Viral | 4 | 2020 | 361 | 0.660 |
Why?
| Bacteriological Techniques | 1 | 2018 | 67 | 0.650 |
Why?
| Gastrointestinal Diseases | 1 | 2020 | 195 | 0.640 |
Why?
| Fecal Microbiota Transplantation | 1 | 2017 | 14 | 0.630 |
Why?
| Immunologic Factors | 1 | 2019 | 228 | 0.610 |
Why?
| Viruses | 5 | 2022 | 98 | 0.600 |
Why?
| Seasons | 6 | 2023 | 468 | 0.580 |
Why?
| Microbial Sensitivity Tests | 2 | 2017 | 312 | 0.580 |
Why?
| Escherichia coli | 1 | 2020 | 767 | 0.570 |
Why?
| Osteoarthritis | 1 | 2018 | 184 | 0.570 |
Why?
| Sensitivity and Specificity | 8 | 2023 | 1855 | 0.560 |
Why?
| Time Factors | 10 | 2021 | 6682 | 0.560 |
Why?
| Viral Tropism | 2 | 2015 | 24 | 0.560 |
Why?
| Phylogeny | 9 | 2016 | 830 | 0.560 |
Why?
| Genome, Viral | 3 | 2016 | 125 | 0.560 |
Why?
| Molecular Epidemiology | 2 | 2017 | 71 | 0.550 |
Why?
| Catheter-Related Infections | 1 | 2016 | 61 | 0.550 |
Why?
| Encephalitis, Viral | 2 | 2020 | 44 | 0.550 |
Why?
| Pregnancy Complications, Infectious | 2 | 2020 | 301 | 0.540 |
Why?
| Adenovirus Infections, Human | 1 | 2015 | 15 | 0.530 |
Why?
| Bacterial Typing Techniques | 1 | 2015 | 43 | 0.530 |
Why?
| Calcitonin | 1 | 2015 | 28 | 0.530 |
Why?
| Catheterization, Central Venous | 1 | 2016 | 95 | 0.520 |
Why?
| Caliciviridae Infections | 1 | 2015 | 20 | 0.520 |
Why?
| Muscle Hypotonia | 1 | 2015 | 29 | 0.520 |
Why?
| Rotavirus Infections | 1 | 2015 | 55 | 0.510 |
Why?
| Whole Genome Sequencing | 1 | 2015 | 114 | 0.500 |
Why?
| Parotitis | 1 | 2014 | 8 | 0.490 |
Why?
| Coronaviridae Infections | 1 | 2014 | 3 | 0.490 |
Why?
| Motor Neurons | 1 | 2016 | 220 | 0.490 |
Why?
| Rubulavirus Infections | 1 | 2013 | 2 | 0.480 |
Why?
| Coronary Artery Disease | 3 | 2018 | 695 | 0.470 |
Why?
| Herpesviridae Infections | 1 | 2015 | 144 | 0.470 |
Why?
| Fever | 6 | 2022 | 289 | 0.460 |
Why?
| Neuraminidase | 3 | 2020 | 24 | 0.450 |
Why?
| United States | 17 | 2022 | 13272 | 0.450 |
Why?
| Coronavirus NL63, Human | 1 | 2012 | 3 | 0.440 |
Why?
| Prevalence | 6 | 2020 | 2442 | 0.440 |
Why?
| Sequence Analysis, DNA | 8 | 2019 | 766 | 0.440 |
Why?
| Sepsis | 1 | 2018 | 546 | 0.430 |
Why?
| Metagenomics | 5 | 2021 | 144 | 0.430 |
Why?
| Streptococcus pneumoniae | 2 | 2023 | 144 | 0.420 |
Why?
| Betacoronavirus | 3 | 2020 | 265 | 0.420 |
Why?
| Viral Envelope Proteins | 1 | 2012 | 81 | 0.420 |
Why?
| Recombination, Genetic | 1 | 2012 | 175 | 0.400 |
Why?
| Cohort Studies | 9 | 2022 | 5294 | 0.400 |
Why?
| Seroepidemiologic Studies | 2 | 2023 | 147 | 0.400 |
Why?
| Acute Disease | 6 | 2023 | 984 | 0.390 |
Why?
| Case-Control Studies | 8 | 2020 | 3296 | 0.390 |
Why?
| Genotype | 3 | 2014 | 1943 | 0.390 |
Why?
| Genetic Variation | 2 | 2014 | 952 | 0.380 |
Why?
| Cluster Analysis | 5 | 2021 | 493 | 0.380 |
Why?
| Streptococcal Infections | 2 | 2023 | 143 | 0.380 |
Why?
| Young Adult | 16 | 2021 | 11094 | 0.370 |
Why?
| Meningitis, Aseptic | 2 | 2020 | 15 | 0.370 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2016 | 534 | 0.370 |
Why?
| Attitude of Health Personnel | 1 | 2017 | 1012 | 0.370 |
Why?
| Membrane Glycoproteins | 1 | 2012 | 462 | 0.360 |
Why?
| Critical Care | 4 | 2021 | 563 | 0.340 |
Why?
| Cross-Sectional Studies | 4 | 2023 | 4734 | 0.330 |
Why?
| Neoplasms | 3 | 2023 | 2235 | 0.330 |
Why?
| Virus Internalization | 4 | 2017 | 42 | 0.320 |
Why?
| Genome, Microbial | 2 | 2019 | 7 | 0.320 |
Why?
| Molecular Sequence Data | 7 | 2015 | 2933 | 0.310 |
Why?
| Mycoplasma pneumoniae | 2 | 2017 | 33 | 0.310 |
Why?
| Immunity, Innate | 1 | 2013 | 762 | 0.310 |
Why?
| Mycoplasma hominis | 1 | 2006 | 4 | 0.290 |
Why?
| Diagnosis, Differential | 7 | 2020 | 1423 | 0.290 |
Why?
| Streptococcus pyogenes | 2 | 2023 | 37 | 0.290 |
Why?
| Treatment Outcome | 7 | 2020 | 9692 | 0.280 |
Why?
| Virus Diseases | 1 | 2008 | 201 | 0.280 |
Why?
| Endocarditis, Bacterial | 1 | 2006 | 38 | 0.280 |
Why?
| Murine hepatitis virus | 2 | 2016 | 16 | 0.280 |
Why?
| Algorithms | 3 | 2023 | 1593 | 0.260 |
Why?
| Immunization | 2 | 2004 | 421 | 0.260 |
Why?
| Prospective Studies | 5 | 2022 | 6704 | 0.260 |
Why?
| Enzyme Inhibitors | 3 | 2020 | 836 | 0.260 |
Why?
| Paraplegia | 2 | 2015 | 63 | 0.250 |
Why?
| Methicillin Resistance | 1 | 2004 | 19 | 0.250 |
Why?
| Apolipoproteins E | 3 | 1999 | 91 | 0.250 |
Why?
| Cellulitis | 1 | 2004 | 48 | 0.240 |
Why?
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 459 | 0.240 |
Why?
| Haemophilus influenzae type b | 1 | 2003 | 10 | 0.240 |
Why?
| Meningitis, Haemophilus | 1 | 2003 | 6 | 0.240 |
Why?
| Coinfection | 2 | 2022 | 122 | 0.240 |
Why?
| Haemophilus Vaccines | 1 | 2003 | 27 | 0.240 |
Why?
| Haemophilus Infections | 1 | 2003 | 32 | 0.240 |
Why?
| Global Health | 2 | 2021 | 352 | 0.240 |
Why?
| Medical Oncology | 2 | 2023 | 231 | 0.230 |
Why?
| Clindamycin | 2 | 2018 | 12 | 0.230 |
Why?
| Antigens, Viral | 3 | 2020 | 181 | 0.230 |
Why?
| Haemophilus influenzae | 1 | 2023 | 51 | 0.230 |
Why?
| Polysaccharides, Bacterial | 1 | 2003 | 68 | 0.230 |
Why?
| Risk Factors | 8 | 2021 | 9381 | 0.230 |
Why?
| Clinical Laboratory Techniques | 2 | 2020 | 93 | 0.220 |
Why?
| Coronavirus 229E, Human | 1 | 2022 | 4 | 0.220 |
Why?
| Metapneumovirus | 1 | 2022 | 13 | 0.220 |
Why?
| Liver Failure, Acute | 1 | 2023 | 68 | 0.220 |
Why?
| Incidence | 3 | 2021 | 2527 | 0.210 |
Why?
| Viral Load | 2 | 2021 | 423 | 0.210 |
Why?
| Logistic Models | 2 | 2018 | 1995 | 0.210 |
Why?
| Pharyngitis | 1 | 2022 | 27 | 0.210 |
Why?
| Reagent Kits, Diagnostic | 2 | 2020 | 44 | 0.210 |
Why?
| North America | 2 | 2016 | 271 | 0.210 |
Why?
| Magnetic Resonance Imaging | 4 | 2018 | 3264 | 0.200 |
Why?
| Abdominal Pain | 2 | 2020 | 141 | 0.200 |
Why?
| Meningoencephalitis | 2 | 2019 | 24 | 0.200 |
Why?
| Protein Structure, Tertiary | 2 | 2015 | 832 | 0.200 |
Why?
| Brain Diseases | 2 | 2020 | 141 | 0.200 |
Why?
| Lethargy | 1 | 2020 | 6 | 0.200 |
Why?
| Lung | 1 | 2014 | 3830 | 0.200 |
Why?
| Asymptomatic Infections | 1 | 2020 | 26 | 0.190 |
Why?
| Intestinal Diseases | 1 | 2020 | 31 | 0.190 |
Why?
| Arbovirus Infections | 1 | 2020 | 17 | 0.190 |
Why?
| Meningitis, Viral | 1 | 2020 | 21 | 0.190 |
Why?
| Staphylococcus aureus | 1 | 2004 | 400 | 0.190 |
Why?
| Length of Stay | 3 | 2020 | 1077 | 0.190 |
Why?
| Encephalitis, Herpes Simplex | 1 | 2020 | 22 | 0.190 |
Why?
| Circulating MicroRNA | 1 | 2020 | 23 | 0.190 |
Why?
| Peptide Fragments | 3 | 1999 | 715 | 0.180 |
Why?
| Myositis | 1 | 2020 | 41 | 0.180 |
Why?
| Vomiting | 1 | 2020 | 126 | 0.180 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 1003 | 0.180 |
Why?
| Medical Records | 2 | 2018 | 181 | 0.180 |
Why?
| Influenza Vaccines | 1 | 2005 | 504 | 0.180 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2020 | 39 | 0.180 |
Why?
| Staphylococcal Infections | 1 | 2004 | 348 | 0.180 |
Why?
| Respiratory Tract Diseases | 1 | 2021 | 140 | 0.180 |
Why?
| Coronary Aneurysm | 1 | 2019 | 11 | 0.180 |
Why?
| Arthritis, Infectious | 1 | 2020 | 52 | 0.180 |
Why?
| Immunocompromised Host | 1 | 2021 | 205 | 0.180 |
Why?
| Exanthema Subitum | 1 | 2019 | 3 | 0.180 |
Why?
| Consciousness Disorders | 1 | 2019 | 20 | 0.180 |
Why?
| Receptors, Lipoprotein | 1 | 1999 | 3 | 0.180 |
Why?
| HIV Infections | 1 | 2014 | 2532 | 0.180 |
Why?
| Heart Defects, Congenital | 1 | 2006 | 721 | 0.180 |
Why?
| Hepatitis | 1 | 2019 | 48 | 0.170 |
Why?
| Taenia solium | 1 | 2018 | 5 | 0.170 |
Why?
| Neurocysticercosis | 1 | 2018 | 6 | 0.170 |
Why?
| Follow-Up Studies | 4 | 2017 | 4768 | 0.170 |
Why?
| Amino Acid Sequence | 5 | 2016 | 2123 | 0.170 |
Why?
| Disease Management | 2 | 2021 | 591 | 0.170 |
Why?
| Abdomen | 1 | 2019 | 117 | 0.170 |
Why?
| Intensive Care Units | 2 | 2015 | 664 | 0.160 |
Why?
| HEK293 Cells | 3 | 2016 | 651 | 0.160 |
Why?
| Immunoglobulin G | 2 | 2020 | 804 | 0.160 |
Why?
| Animals | 14 | 2022 | 34133 | 0.160 |
Why?
| Antibodies, Viral | 3 | 2020 | 551 | 0.160 |
Why?
| Vero Cells | 2 | 2015 | 69 | 0.160 |
Why?
| Body Fluids | 1 | 2018 | 66 | 0.160 |
Why?
| Methyltransferases | 1 | 2018 | 63 | 0.160 |
Why?
| Epithelial Cells | 2 | 2015 | 995 | 0.160 |
Why?
| Lipoproteins | 1 | 1999 | 164 | 0.160 |
Why?
| Adult | 13 | 2023 | 32385 | 0.160 |
Why?
| Sequence Alignment | 2 | 2016 | 343 | 0.160 |
Why?
| Chlamydophila pneumoniae | 1 | 2017 | 11 | 0.160 |
Why?
| Mycoplasma Infections | 1 | 2017 | 13 | 0.160 |
Why?
| Heparin | 1 | 2019 | 240 | 0.160 |
Why?
| Canada | 2 | 2016 | 355 | 0.160 |
Why?
| Receptors, Immunologic | 1 | 1999 | 228 | 0.160 |
Why?
| Controlled Before-After Studies | 1 | 2017 | 16 | 0.160 |
Why?
| Severity of Illness Index | 3 | 2021 | 2784 | 0.160 |
Why?
| Chronic Disease | 1 | 2023 | 1645 | 0.150 |
Why?
| Prognosis | 2 | 2016 | 3563 | 0.150 |
Why?
| Databases, Factual | 1 | 2023 | 1287 | 0.150 |
Why?
| Antibodies, Monoclonal | 2 | 2015 | 1306 | 0.150 |
Why?
| Organ Transplantation | 1 | 2020 | 165 | 0.150 |
Why?
| Stomach | 1 | 2017 | 109 | 0.150 |
Why?
| Intubation, Gastrointestinal | 1 | 2017 | 61 | 0.150 |
Why?
| Mouth Mucosa | 1 | 2017 | 81 | 0.150 |
Why?
| Specimen Handling | 1 | 2018 | 169 | 0.150 |
Why?
| Decision Support Systems, Clinical | 1 | 2020 | 180 | 0.150 |
Why?
| Inflammation | 2 | 2018 | 2598 | 0.150 |
Why?
| Movement Disorders | 1 | 2017 | 45 | 0.150 |
Why?
| Densovirus | 1 | 2016 | 2 | 0.150 |
Why?
| Gastrostomy | 1 | 2017 | 93 | 0.150 |
Why?
| Electromyography | 2 | 2017 | 334 | 0.150 |
Why?
| Seizures | 1 | 2020 | 360 | 0.150 |
Why?
| Urban Population | 1 | 2019 | 425 | 0.150 |
Why?
| Middle East Respiratory Syndrome Coronavirus | 1 | 2016 | 3 | 0.140 |
Why?
| Muscular Diseases | 1 | 2017 | 108 | 0.140 |
Why?
| Vaccination | 1 | 2005 | 1241 | 0.140 |
Why?
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2016 | 14 | 0.140 |
Why?
| Encephalomyelitis | 1 | 2016 | 9 | 0.140 |
Why?
| Dendritic Spines | 1 | 2016 | 52 | 0.140 |
Why?
| Lyme Disease | 1 | 2016 | 32 | 0.140 |
Why?
| Syncope | 1 | 2016 | 35 | 0.140 |
Why?
| Balamuthia mandrillaris | 1 | 2015 | 4 | 0.140 |
Why?
| Amebiasis | 1 | 2015 | 5 | 0.140 |
Why?
| Still's Disease, Adult-Onset | 1 | 1995 | 4 | 0.140 |
Why?
| Stomach Ulcer | 1 | 1995 | 9 | 0.140 |
Why?
| Bacterial Proteins | 2 | 2018 | 775 | 0.140 |
Why?
| Bradycardia | 1 | 2016 | 58 | 0.140 |
Why?
| Genome, Mitochondrial | 1 | 2015 | 26 | 0.140 |
Why?
| Madin Darby Canine Kidney Cells | 1 | 2015 | 14 | 0.140 |
Why?
| Cephalosporins | 1 | 2015 | 30 | 0.130 |
Why?
| Rural Population | 1 | 2019 | 482 | 0.130 |
Why?
| Early Diagnosis | 1 | 2016 | 242 | 0.130 |
Why?
| Colonoscopy | 1 | 2017 | 208 | 0.130 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 16 | 0.130 |
Why?
| Sapovirus | 1 | 2015 | 2 | 0.130 |
Why?
| Reproducibility of Results | 1 | 2023 | 2977 | 0.130 |
Why?
| Cells, Cultured | 2 | 2014 | 4162 | 0.130 |
Why?
| Peritonitis | 1 | 1995 | 78 | 0.130 |
Why?
| Rotavirus | 1 | 2015 | 27 | 0.130 |
Why?
| Cell Line, Transformed | 1 | 2015 | 140 | 0.130 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 410 | 0.130 |
Why?
| Norovirus | 1 | 2015 | 25 | 0.130 |
Why?
| Virus Shedding | 1 | 2015 | 47 | 0.130 |
Why?
| RNA Viruses | 1 | 2015 | 31 | 0.130 |
Why?
| Liver Transplantation | 1 | 2023 | 929 | 0.130 |
Why?
| Echocardiography, Doppler | 1 | 2015 | 105 | 0.130 |
Why?
| Recurrence | 1 | 2017 | 998 | 0.130 |
Why?
| Immunoglobulins | 1 | 2015 | 166 | 0.130 |
Why?
| Bacterial Shedding | 1 | 2014 | 3 | 0.130 |
Why?
| Echocardiography | 2 | 2019 | 591 | 0.130 |
Why?
| Health Resources | 1 | 2016 | 136 | 0.130 |
Why?
| Microscopy, Electron | 1 | 2015 | 418 | 0.120 |
Why?
| Biopsy | 1 | 2018 | 1090 | 0.120 |
Why?
| Zanamivir | 1 | 2014 | 1 | 0.120 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 543 | 0.120 |
Why?
| Cost of Illness | 1 | 2016 | 284 | 0.120 |
Why?
| Infection Control | 1 | 2015 | 138 | 0.120 |
Why?
| Oseltamivir | 1 | 2014 | 12 | 0.120 |
Why?
| Dogs | 1 | 2015 | 382 | 0.120 |
Why?
| Particulate Matter | 1 | 2016 | 257 | 0.120 |
Why?
| Parainfluenza Virus 4, Human | 1 | 2013 | 2 | 0.120 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 302 | 0.120 |
Why?
| Molecular Typing | 1 | 2013 | 19 | 0.120 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 432 | 0.120 |
Why?
| Acute Kidney Injury | 1 | 2021 | 755 | 0.120 |
Why?
| Giant Cells | 1 | 2013 | 22 | 0.120 |
Why?
| Disease Reservoirs | 1 | 2013 | 24 | 0.120 |
Why?
| Drug Therapy, Combination | 2 | 2013 | 988 | 0.120 |
Why?
| Brazil | 1 | 2013 | 111 | 0.120 |
Why?
| Pediatrics | 3 | 2020 | 1009 | 0.120 |
Why?
| Mexico | 1 | 2013 | 165 | 0.110 |
Why?
| Radiography, Thoracic | 1 | 2014 | 168 | 0.110 |
Why?
| Respiratory Mucosa | 1 | 2015 | 263 | 0.110 |
Why?
| Oxygen | 2 | 2023 | 887 | 0.110 |
Why?
| Membrane Proteins | 1 | 1999 | 1093 | 0.110 |
Why?
| Orthomyxoviridae | 1 | 2012 | 38 | 0.110 |
Why?
| Biomarkers | 3 | 2021 | 3662 | 0.110 |
Why?
| Neuroimaging | 1 | 2014 | 261 | 0.110 |
Why?
| Environmental Exposure | 1 | 2016 | 427 | 0.110 |
Why?
| Glucocorticoids | 2 | 2013 | 554 | 0.110 |
Why?
| Temperature | 1 | 2015 | 631 | 0.100 |
Why?
| Anti-Retroviral Agents | 1 | 2014 | 208 | 0.100 |
Why?
| Antibodies, Neutralizing | 1 | 2014 | 229 | 0.100 |
Why?
| Brain | 3 | 2018 | 2540 | 0.100 |
Why?
| Treatment Failure | 1 | 2013 | 348 | 0.100 |
Why?
| Inpatients | 1 | 2015 | 402 | 0.100 |
Why?
| Illinois | 2 | 2015 | 39 | 0.100 |
Why?
| Ventricular Dysfunction, Left | 1 | 2015 | 401 | 0.100 |
Why?
| Gastrointestinal Microbiome | 1 | 2018 | 561 | 0.100 |
Why?
| Liver Function Tests | 1 | 2011 | 114 | 0.100 |
Why?
| Critical Illness | 1 | 2016 | 728 | 0.100 |
Why?
| Peptides | 1 | 2016 | 893 | 0.100 |
Why?
| Age Factors | 2 | 2010 | 3114 | 0.090 |
Why?
| Intestines | 1 | 2013 | 338 | 0.090 |
Why?
| Macrophages, Alveolar | 1 | 2013 | 364 | 0.090 |
Why?
| Aspirin | 1 | 2013 | 344 | 0.090 |
Why?
| Middle Aged | 10 | 2020 | 28563 | 0.090 |
Why?
| Community-Acquired Infections | 2 | 2017 | 148 | 0.090 |
Why?
| Interleukin-6 | 1 | 2013 | 702 | 0.090 |
Why?
| Cell Line | 5 | 2017 | 2785 | 0.090 |
Why?
| Ear Diseases | 1 | 1988 | 15 | 0.080 |
Why?
| Cholesteatoma | 1 | 1988 | 14 | 0.080 |
Why?
| Cleft Palate | 1 | 1988 | 53 | 0.080 |
Why?
| Liver Diseases | 1 | 2011 | 325 | 0.080 |
Why?
| Muscle, Skeletal | 1 | 2017 | 1556 | 0.080 |
Why?
| Lipoproteins, LDL | 2 | 1999 | 138 | 0.080 |
Why?
| Diagnostic Errors | 1 | 2008 | 171 | 0.080 |
Why?
| Patient Admission | 1 | 2008 | 195 | 0.070 |
Why?
| Cross-Over Studies | 2 | 2019 | 469 | 0.070 |
Why?
| Immunoassay | 1 | 2006 | 101 | 0.070 |
Why?
| Odds Ratio | 2 | 2021 | 1043 | 0.070 |
Why?
| Mice | 6 | 2022 | 15888 | 0.060 |
Why?
| Chicago | 1 | 2004 | 43 | 0.060 |
Why?
| Population Surveillance | 1 | 2008 | 439 | 0.060 |
Why?
| Models, Molecular | 3 | 2017 | 1443 | 0.060 |
Why?
| Adrenal Cortex Hormones | 2 | 2020 | 515 | 0.060 |
Why?
| Hepacivirus | 1 | 2006 | 234 | 0.060 |
Why?
| Tomography, X-Ray Computed | 1 | 2014 | 2500 | 0.060 |
Why?
| Bacterial Capsules | 1 | 2003 | 29 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2020 | 1947 | 0.060 |
Why?
| Base Sequence | 1 | 2007 | 2186 | 0.060 |
Why?
| Hepatitis C | 1 | 2006 | 226 | 0.060 |
Why?
| Streptococcus | 1 | 2023 | 25 | 0.060 |
Why?
| Computational Biology | 2 | 2019 | 601 | 0.060 |
Why?
| Guidelines as Topic | 1 | 2005 | 273 | 0.060 |
Why?
| Minnesota | 1 | 2023 | 143 | 0.050 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2023 | 346 | 0.050 |
Why?
| Respiratory System | 1 | 2023 | 144 | 0.050 |
Why?
| Heparin Lyase | 2 | 1999 | 4 | 0.050 |
Why?
| Immunization Schedule | 1 | 2003 | 187 | 0.050 |
Why?
| Immunologic Surveillance | 1 | 2022 | 20 | 0.050 |
Why?
| Republic of Korea | 1 | 2021 | 28 | 0.050 |
Why?
| Data Collection | 1 | 2005 | 667 | 0.050 |
Why?
| New Zealand | 1 | 2021 | 53 | 0.050 |
Why?
| Italy | 1 | 2021 | 95 | 0.050 |
Why?
| History, 21st Century | 1 | 2022 | 177 | 0.050 |
Why?
| Immunization Programs | 1 | 2003 | 210 | 0.050 |
Why?
| Embryo, Mammalian | 2 | 1999 | 222 | 0.050 |
Why?
| Monte Carlo Method | 1 | 2021 | 149 | 0.050 |
Why?
| Schools | 1 | 2004 | 428 | 0.050 |
Why?
| Public Health Surveillance | 1 | 2021 | 63 | 0.050 |
Why?
| Conserved Sequence | 2 | 1998 | 220 | 0.050 |
Why?
| Nucleocapsid Proteins | 1 | 2020 | 24 | 0.050 |
Why?
| Societies, Medical | 1 | 2005 | 741 | 0.050 |
Why?
| Aged | 4 | 2020 | 20495 | 0.050 |
Why?
| Oropharynx | 1 | 2020 | 41 | 0.050 |
Why?
| Serologic Tests | 1 | 2020 | 56 | 0.050 |
Why?
| Immunization, Passive | 1 | 2020 | 82 | 0.050 |
Why?
| Receptors, LDL | 2 | 1998 | 41 | 0.050 |
Why?
| Discriminant Analysis | 1 | 2020 | 43 | 0.050 |
Why?
| Living Donors | 1 | 2023 | 322 | 0.050 |
Why?
| Asymptomatic Diseases | 1 | 2020 | 83 | 0.050 |
Why?
| Confusion | 1 | 2020 | 27 | 0.050 |
Why?
| Symptom Assessment | 1 | 2021 | 124 | 0.050 |
Why?
| Chlorates | 1 | 1999 | 4 | 0.040 |
Why?
| Immunocompetence | 1 | 2019 | 45 | 0.040 |
Why?
| Scavenger Receptors, Class B | 1 | 1999 | 9 | 0.040 |
Why?
| Scavenger Receptors, Class A | 1 | 1999 | 9 | 0.040 |
Why?
| Receptors, Scavenger | 1 | 1999 | 12 | 0.040 |
Why?
| Egtazic Acid | 1 | 1999 | 45 | 0.040 |
Why?
| Picornaviridae | 1 | 2019 | 18 | 0.040 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 2020 | 159 | 0.040 |
Why?
| Health Personnel | 1 | 2005 | 603 | 0.040 |
Why?
| Antibodies, Helminth | 1 | 2018 | 11 | 0.040 |
Why?
| Infant, Newborn, Diseases | 1 | 2020 | 108 | 0.040 |
Why?
| C-Reactive Protein | 1 | 2021 | 363 | 0.040 |
Why?
| Europe | 1 | 2020 | 369 | 0.040 |
Why?
| Linear Models | 1 | 2021 | 854 | 0.040 |
Why?
| Lipoproteins, HDL | 1 | 1999 | 82 | 0.040 |
Why?
| Blood | 1 | 1999 | 100 | 0.040 |
Why?
| Parasites | 1 | 2019 | 43 | 0.040 |
Why?
| Gene Regulatory Networks | 1 | 2020 | 244 | 0.040 |
Why?
| Plasma | 1 | 2020 | 223 | 0.040 |
Why?
| Drug Resistance | 1 | 2019 | 169 | 0.040 |
Why?
| Transplant Recipients | 1 | 2020 | 149 | 0.040 |
Why?
| Child Health Services | 1 | 2020 | 180 | 0.040 |
Why?
| Lactams | 1 | 1998 | 39 | 0.040 |
Why?
| Leukocyte Count | 1 | 2018 | 309 | 0.040 |
Why?
| Arboviruses | 1 | 2017 | 9 | 0.040 |
Why?
| Phosphoproteins | 1 | 2020 | 332 | 0.040 |
Why?
| Comparative Effectiveness Research | 1 | 2019 | 142 | 0.040 |
Why?
| Clinical Competence | 1 | 2005 | 973 | 0.040 |
Why?
| Headache | 1 | 2018 | 134 | 0.040 |
Why?
| Structural Homology, Protein | 1 | 2017 | 24 | 0.040 |
Why?
| Genes, Bacterial | 1 | 2018 | 165 | 0.040 |
Why?
| Fibroblasts | 2 | 1999 | 846 | 0.040 |
Why?
| Contact Tracing | 1 | 2017 | 27 | 0.040 |
Why?
| Drug Administration Schedule | 1 | 2019 | 757 | 0.040 |
Why?
| Bacterial Toxins | 1 | 2018 | 107 | 0.040 |
Why?
| Epitope Mapping | 1 | 2017 | 49 | 0.040 |
Why?
| Models, Chemical | 1 | 1999 | 273 | 0.040 |
Why?
| RNA | 1 | 2023 | 854 | 0.040 |
Why?
| Gastrointestinal Tract | 1 | 2019 | 176 | 0.040 |
Why?
| Neural Conduction | 1 | 2017 | 82 | 0.040 |
Why?
| Glutamate Plasma Membrane Transport Proteins | 1 | 2016 | 5 | 0.040 |
Why?
| Genomics | 1 | 2022 | 714 | 0.040 |
Why?
| Administration, Oral | 1 | 2019 | 786 | 0.040 |
Why?
| Mutant Proteins | 1 | 2017 | 101 | 0.040 |
Why?
| Atrophy | 1 | 2017 | 167 | 0.040 |
Why?
| Macrolides | 1 | 2017 | 66 | 0.040 |
Why?
| Eosinophilia | 1 | 2018 | 177 | 0.040 |
Why?
| Sequence Homology | 1 | 2016 | 40 | 0.040 |
Why?
| RNA, Bacterial | 1 | 2018 | 180 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2019 | 420 | 0.040 |
Why?
| Pyramidal Cells | 1 | 2016 | 54 | 0.040 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2016 | 83 | 0.040 |
Why?
| Urban Health | 1 | 2016 | 89 | 0.040 |
Why?
| Health Information Systems | 1 | 2016 | 18 | 0.040 |
Why?
| Membrane Fusion | 1 | 2016 | 40 | 0.040 |
Why?
| Naproxen | 1 | 1995 | 12 | 0.030 |
Why?
| Protein Multimerization | 1 | 2017 | 165 | 0.030 |
Why?
| Open Reading Frames | 1 | 2016 | 121 | 0.030 |
Why?
| Protein Domains | 1 | 2017 | 219 | 0.030 |
Why?
| Comorbidity | 1 | 2021 | 1600 | 0.030 |
Why?
| Crystallography, X-Ray | 1 | 2017 | 430 | 0.030 |
Why?
| Missouri | 1 | 2015 | 65 | 0.030 |
Why?
| Prednisolone | 1 | 1995 | 76 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2019 | 515 | 0.030 |
Why?
| RNA, Ribosomal, 16S | 1 | 2018 | 535 | 0.030 |
Why?
| Particle Size | 1 | 2016 | 344 | 0.030 |
Why?
| Patient Reported Outcome Measures | 1 | 2017 | 258 | 0.030 |
Why?
| Epitopes | 1 | 2017 | 450 | 0.030 |
Why?
| Wnt Signaling Pathway | 1 | 2016 | 153 | 0.030 |
Why?
| Diastole | 1 | 2015 | 147 | 0.030 |
Why?
| Cough | 1 | 2015 | 104 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2019 | 1981 | 0.030 |
Why?
| Systole | 1 | 2015 | 178 | 0.030 |
Why?
| Respiratory Sounds | 1 | 2015 | 119 | 0.030 |
Why?
| beta Catenin | 1 | 2016 | 223 | 0.030 |
Why?
| Cote d'Ivoire | 1 | 2014 | 9 | 0.030 |
Why?
| Vietnam | 1 | 2014 | 23 | 0.030 |
Why?
| Protein Binding | 2 | 2017 | 2010 | 0.030 |
Why?
| DNA, Viral | 1 | 2016 | 358 | 0.030 |
Why?
| Dyspnea | 1 | 2015 | 214 | 0.030 |
Why?
| Brain Stem | 1 | 2014 | 104 | 0.030 |
Why?
| Biodiversity | 1 | 2018 | 386 | 0.030 |
Why?
| Gene Order | 1 | 2013 | 29 | 0.030 |
Why?
| Social Behavior | 1 | 2016 | 291 | 0.030 |
Why?
| Lentivirus | 1 | 2013 | 52 | 0.030 |
Why?
| Kidney | 1 | 2021 | 1355 | 0.030 |
Why?
| Trypsin | 1 | 2013 | 72 | 0.030 |
Why?
| California | 1 | 2015 | 387 | 0.030 |
Why?
| Cell Membrane | 2 | 2013 | 741 | 0.030 |
Why?
| Anxiety Disorders | 1 | 2016 | 326 | 0.030 |
Why?
| Depressive Disorder | 1 | 2016 | 347 | 0.030 |
Why?
| Synapses | 1 | 2016 | 347 | 0.030 |
Why?
| Endosomes | 1 | 2013 | 129 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2020 | 1519 | 0.030 |
Why?
| Exanthema | 1 | 2013 | 78 | 0.030 |
Why?
| Evolution, Molecular | 1 | 2016 | 459 | 0.030 |
Why?
| Hydrogen-Ion Concentration | 1 | 2013 | 547 | 0.030 |
Why?
| Macrophages | 1 | 1999 | 1334 | 0.030 |
Why?
| Gene Deletion | 1 | 2013 | 365 | 0.030 |
Why?
| Respiration, Artificial | 1 | 2015 | 596 | 0.020 |
Why?
| Emergency Service, Hospital | 1 | 2022 | 1922 | 0.020 |
Why?
| gamma-Glutamyltransferase | 1 | 2011 | 44 | 0.020 |
Why?
| Bilirubin | 1 | 2011 | 95 | 0.020 |
Why?
| Aspartate Aminotransferases | 1 | 2011 | 96 | 0.020 |
Why?
| Proportional Hazards Models | 1 | 2014 | 1184 | 0.020 |
Why?
| Alanine Transaminase | 1 | 2011 | 152 | 0.020 |
Why?
| Mice, Knockout | 1 | 2016 | 2737 | 0.020 |
Why?
| Anxiety | 1 | 2016 | 888 | 0.020 |
Why?
| Risk Assessment | 1 | 2019 | 3213 | 0.020 |
Why?
| Iowa | 1 | 1988 | 27 | 0.020 |
Why?
| Otitis Media with Effusion | 1 | 1988 | 20 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2016 | 2127 | 0.020 |
Why?
| Pregnancy | 1 | 2020 | 5854 | 0.020 |
Why?
| Mental Disorders | 1 | 2016 | 952 | 0.020 |
Why?
| Gene Expression | 1 | 2013 | 1506 | 0.020 |
Why?
| Depression | 1 | 2016 | 1190 | 0.020 |
Why?
| Referral and Consultation | 1 | 2013 | 669 | 0.020 |
Why?
| Capsid Proteins | 1 | 2008 | 70 | 0.020 |
Why?
| Hepatitis C Antigens | 1 | 2006 | 1 | 0.020 |
Why?
| Hepatitis C Antibodies | 1 | 2006 | 10 | 0.020 |
Why?
| Viral Proteins | 1 | 2008 | 300 | 0.020 |
Why?
| Mutation | 1 | 2016 | 3493 | 0.020 |
Why?
| HIV Seropositivity | 1 | 2006 | 117 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2015 | 6845 | 0.010 |
Why?
| Asthma | 1 | 2015 | 2130 | 0.010 |
Why?
| Circular Dichroism | 1 | 1998 | 138 | 0.010 |
Why?
| Iodine Radioisotopes | 1 | 1998 | 128 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 1998 | 341 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 1998 | 536 | 0.010 |
Why?
| Polysaccharide-Lyases | 1 | 1996 | 13 | 0.010 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 241 | 0.010 |
Why?
| Binding, Competitive | 1 | 1996 | 205 | 0.010 |
Why?
| In Vitro Techniques | 1 | 1996 | 1130 | 0.010 |
Why?
| Protein Conformation | 1 | 1996 | 851 | 0.010 |
Why?
| Binding Sites | 1 | 1996 | 1247 | 0.010 |
Why?
| Liver | 1 | 1996 | 1827 | 0.010 |
Why?
| Rats | 1 | 1996 | 5426 | 0.000 |
Why?
|
|
Dominguez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|